Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stryker Completes Surpass Acquisition - Orthopedic Design & Technology

Stryker Completes Surpass Acquisition

Purchase is not expected to affect Stryker's 2012 earnings per share.

Kalamazoo, Mich.-based Stryker Corp., has completed its acquisition of Surpass Medical Ltd. Surpass is developing and commercializing the NeuroEndGraft family of flow diversion stent technology to treat brain aneurysms using a mesh design and delivery system.

“With the acquisition of Surpass Medical we are continuing to expand our global product portfolio in the fast growing and neurovascular market by offering patients and caregivers differentiated products focused on Complete Stroke Care,” said Kevin A. Lobo, Stryker president and CEO.

When the acquisition was first announced in mid-October, company officials said they expected it to be neutral to Stryker’s 2012 earnings per share excluding purchase and integration-related charges.

Stryker offers reconstructive, medical, and surgical products in the neurotechnology and orthopedics spaces.



Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters